Is continuous venovenous hemofiltration effective against severe acute pancreatitis?

Artificial Organs

Volumn 37, Issue 7, 2013, Pages 615-622

  Wang, Shiqi ^a   Xu, Lei ^b   Feng, Xiangying ^a   Li, Shujun ^a   Feng, Quanxin ^a   Liu, Chaoxu ^a   Zhang, Xujie ^a   Zhao, Qingchuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute pancreatitis; Hemofiltration; Prognosis

Indexed keywords

FLOW OF FLUIDS; POPULATION STATISTICS;

ACUTE PANCREATITIS; COMPARATIVES STUDIES; CYTOKINES; HEMOFILTRATION; HIGH VOLUMES; LITERATURE SEARCH; MORTALITY RATE; PROGNOSE; SEVERE ACUTE PANCREATITIS; STARTING TIME;

DIAGNOSIS;

CALCIUM; CREATININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; PHOSPHOLIPASE A2; THROMBOMODULIN; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ALKALOSIS; APACHE; ARTICLE; CALCIUM BLOOD LEVEL; CLEARANCE; CLINICAL EFFECTIVENESS; CONTINUOUS HEMOFILTRATION; CREATININE BLOOD LEVEL; ELECTRIC RESISTANCE; ENZYME BLOOD LEVEL; ENZYME METABOLISM; EPITHELIUM CELL; FLUID FLOW; HUMAN; MEMBRANE FILTER; MONOCYTE; MORTALITY; PERMEABILITY; PRIORITY JOURNAL; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; URINE VOLUME; VITAL SIGN;

EID: 84880253126     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12051     Document Type: Article

References (24)

1. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002;9:401-410.
2. Hongo H, Takano H, Imai A, etal. Pancreatic phospholipase A2 induces bacterial translocation in rats. Immunopharmacol Immunotoxicol 1999;21:717-726.
3. Tsukahara Y, Morisaki T, Horita Y, Torisu M, Tanaka M. Phospholipase A2 mediates nitric oxide production by alveolar macrophages and acute lung injury in pancreatitis. Ann Surg 1999;229:385-392.
4. Hartwig W, Werner J, Jimenez RE, etal. Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury. Am J Physiol 1999;277:G1008-1016.
5. Zhu Y, Yuan J, Zhang P, etal. Adjunctive continuous high-volume hemofiltration in patients with acute severe pancreatitis: a prospective nonrandomized study. Pancreas 2011;40:109-113.
6. Abe R, Oda S, Shinozaki K, Hirasawa H. Continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter for severe acute pancreatitis. Contrib Nephrol 2010;166:54-63.
7. Gong D, Zhang P, Ji D, etal. Improvement of immune dysfunction in patients with severe acute pancreatitis by high-volume hemofiltration: a preliminary report. Int J Artif Organs 2010;33:22-29.
8. Zhang J, Yuan C, Hua G, Tong R, Luo X, Ying Z. Early gut barrier dysfunction in patients with severe acute pancreatitis: attenuated by continuous blood purification treatment. Int J Artif Organs 2010;33:706-715.
9. Zhu Y, Zhang P, Yuan J, etal. Adjunctive continuous high-volume hemofiltration in acute severe pancreatitis patients: a retrospective study. Scand J Gastroenterol 2009;44:1363-1369.
10. Yu C, Liu ZH, Chen ZH, Gong DH, Ji DX, Li LS. Improvement of monocyte function and immune homeostasis by high volume continuous venovenous hemofiltration in patients with severe acute pancreatitis. Int J Artif Organs 2008;31:882-890.
11. Chen ZH, Liu ZH, Yu C, Ji DX, Li LS. Endothelial dysfunction in patients with severe acute pancreatitis: improved by continuous blood purification therapy. Int J Artif Organs 2007;30:393-400.
12. Okita Y, Okahisa T, Sogabe M, Suzuki M, Ohnishi Y, Ito S. Low-volume continuous hemodiafiltration with nafamostat mesilate increases trypsin clearance without decreasing plasma trypsin concentration in severe acute pancreatitis. ASAIO J 2007;53:207-212.
13. Suzuki M, Okahisa T, Sogabe M, etal. Kinetics of group IB and IIA phospholipase A2 during low-volume continuous hemodiafiltration in severe acute pancreatitis. Artif Organs 2007;31:395-401.
14. Jiang HL, Xue WJ, Li DQ, etal. Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 2005;11:4815-4821.
15. Oda S, Hirasawa H, Shiga H, etal. Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter. Ther Apher Dial 2005;9:355-361.
16. Wang H, Li WQ, Zhou W, Li N, Li JS. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol 2003;9:2096-2099.
17. Xie H, Ji D, Gong D, etal. Continuous veno venous hemofiltration in treatment of acute necrotizing pancreatitis. Chin Med J (Engl) 2003;116:549-553.
18. Bradley ER. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993;128:586-590.
19. Haenisch B, von Kugelgen I, Bonisch H, etal. Regulatory mechanisms underlying agmatine homeostasis in humans. Am J Physiol Gastrointest Liver Physiol 2008;295:G1104-1110.
20. Gabryelewicz A, Kosidlo S, Prokopowicz J, Podkowicz K. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats. Hepatogastroenterology 1986;33:79-82.
21. Qiu F, Lu XS, Huang YK. Effect of low molecular weight heparin on pancreatic micro-circulation in severe acute pancreatitis in a rodent model. Chin Med J (Engl) 2007;120:2260-2263.
22. Lu XS, Qiu F, Li JQ, etal. Low molecular weight heparin in the treatment of severe acute pancreatitis: a multiple centre prospective clinical study. Asian J Surg 2009;32:89-94.
23. Lee JK, Ryu JK, Park JK, etal. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis. Pancreas 2008;36:255-260.
24. Park KT, Kang DH, Choi CW, etal. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients? Pancreas 2011;40:1215-1219.